Sechenov School
Home › Pharmacology › Affinity and Intrinsic Activity

Affinity and Intrinsic Activity

For medical students2 min readUpdated 2026-10-10

Affinity refers to the ability of a pharmacological agent to bind to a receptor, forming a drug-receptor complex. However, binding alone is insufficient to produce a biological response; therefore, intrinsic activity—the ability of a molecule to stimulate the receptor and trigger an effect—plays a decisive role.

AffinityDetermines the binding strength between a drug molecule and its receptor.
EquilibriumReceptor interaction is governed by the law of mass action.
Kd ConstantThe concentration at which exactly 50% of all receptors are occupied by the drug.
EC50 IndexThe drug concentration required to produce 50% of the maximum biological effect.
Key RequirementWithout intrinsic activity, a pharmacological effect will not occur.

Receptor Interaction Dynamics

The binding of any pharmacological agent to a specific target strictly follows the law of mass action. Two simultaneous and parallel processes occur within a biological system: the formation of the drug-receptor complex and its dissociation.

Dynamic equilibrium is reached when the rate of formation of new complexes equals the rate of their dissociation. Mathematically, this is expressed by the classical equation: $k_1 \cdot [B] \cdot [P] = k_2 \cdot [BP]$

Where:

Affinity and the Dissociation Constant

Affinity (derived from the Latin affinis, meaning "related") is the intrinsic ability of a chemical substance to bind to a receptor. Physically, it represents the stability of the formed bond. The more stable the bond, the longer the complex persists before natural dissociation.

Quantitative measure of this stability is the dissociation constant ($K_d$). It is calculated as the ratio of the dissociation rate constant to the association rate constant ($K_d = k_2 / k_1$). At equilibrium, the formula is: $K_d = ([B] \cdot [P]) / [BP]$

Key principle: the relationship between $K_d$ and affinity is inversely proportional. The lower the $K_d$ value, the higher the affinity (the molecule binds more tightly). Conversely, the higher the $K_d$, the lower the affinity. For example, a drug with $K_d = 10^{-10}$ M has a significantly higher affinity than a substance with $K_d = 10^{-3}$ M. This parameter is measured in moles per liter (M).

Fraction of Occupied Receptors and Graphical Analysis

To assess the extent of binding, the fraction of occupied receptors ($f$) is used. It represents the ratio of bound receptors to the total number of receptors. This fraction can be calculated using concentration: $f = [B] / ([B] + K_d)$

This formula yields a fundamental rule explaining the physical meaning of $K_d$. If the free drug concentration equals the dissociation constant ($[B] = K_d$), the fraction of occupied receptors is exactly $1/2$ (or 0.5). Thus, $K_d$ is the concentration at which 50% of the available receptors are occupied.

Grafically, binding is represented as a semilogarithmic sigmoidal curve, plotting the percentage of binding on the Y-axis against the log of concentration on the X-axis. If a drug's curve is shifted to the left, it achieves 50% binding at a lower concentration, indicating a higher receptor affinity.

Intrinsic Activity and Pharmacological Effect

High affinity ensures stable binding but does not guarantee the expected biological effect. To elicit a biological response, the drug must possess intrinsic activity—the ability of the molecule to activate the receptor upon binding, initiating a signaling cascade. Based on this property, drugs are divided into two major groups: agonists and antagonists.

The dissociation constant often correlates with final drug potency: a lower $K_d$ typically implies a stronger action. However, for precise effect evaluation, the half-maximal effective concentration ($EC_{50}$) is used. This is the drug concentration that produces 50% of the maximum biological response.

On a log concentration-response curve, the same logic applies: the lower the concentration required to reach $EC_{50}$ (curve positioned further to the left), the higher the intrinsic potency of the substance.

Mnemonic

To easily remember the relationship between affinity and Kd, imagine Kd as the "price" of a receptor. The lower the "price" (smaller Kd value), the easier it is for the drug to "buy" a bond, and therefore the higher its binding ability (affinity).

Frequently asked questions

How do agonists and antagonists differ in terms of intrinsic activity?

Agonists and antagonists differ by the presence or absence of the ability to elicit a biological response upon receptor interaction.

Drug ClassIntrinsic ActivityEffect
AgonistsPresentStimulate the receptor
AntagonistsAbsentDo not stimulate the receptor

Agonists possess intrinsic activity. Antagonists have affinity but completely lack intrinsic activity. They bind to the receptor, blocking endogenous ligands or exogenous agonists, while their clinical effect is secondary, resulting from the prevention of natural stimulation.

What are the types of antagonists based on their interaction mechanism?

Based on the mechanism of receptor interaction, antagonists are divided into competitive and noncompetitive.

  • Competitive antagonists compete with agonists for the binding site and can be displaced by increasing agonist concentrations.
  • Noncompetitive antagonists bind to allosteric sites on the macromolecule or form stable covalent bonds.

In noncompetitive antagonism, receptor conformation changes, causing a loss of ability to interact with the agonist. Increasing agonist concentration does not fully restore the effect in this case.

What units are used to measure the dissociation constant?

The dissociation constant ($K_d$) is expressed in moles per liter (M). Numerically, it equals the drug concentration at which exactly half of the receptors in the system are occupied.

How are Kd and drug affinity related?

Their relationship is inversely proportional. The lower the $K_d$ value, the higher the affinity of the molecule for the receptor and the stronger their physical binding.

What is EC50 and how does it differ from Kd?

$EC_{50}$ is the effective concentration that produces 50% of the maximum biological response (describing the effect). $K_d$, on the other hand, reflects exclusively binding strength (50% receptor occupancy), regardless of the magnitude of the resulting effect.

Is high affinity sufficient to produce a pharmacological effect?

No, binding alone is not enough. The molecule must also possess intrinsic activity—the ability to stimulate the receptor after the complex is formed.

Go deeper

More topics in Pharmacology

Central AnticholinergicsVerapamilBromhexineNon-Glycoside CardiotonicsAnticholinergics in GastroenterologyEndocytosis and Paracellular TransportChronopharmacologyDrug AllergyAcute Morphine PoisoningAtypical AntipsychoticsHemostasisHemostasis and ThrombosisPharmacology →